Trial cohorts

Find up-to-date information on the trial cohorts open and closed to recruitment

OCTAVE Cohorts open to recruitment:

1. Deep Immunophenotyping Group (150 patients per cohort) - Closed

Rheumatic/Inflammatory conditions

Rheumatic, liver and renal conditions are closed

Cancer

Chronic liver conditions (including organ transplant) and inflammatory bowel disease

Chronic renal conditions (including organ transplant)

Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T recipients

2. Serology Group (850 patient per cohort) - Closed

Rheumatic/Inflammatory conditions

Cancer

Chronic liver conditions (including organ transplant) and inflammatory bowel disease

Chronic renal conditions (including organ transplant)

Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T recipients

Renal conditions is closed

3. Serology Plus Group (up to 160 patient per cohort) - Closed

Childhood/juvenile Rheumatic/Inflammatory conditions

Childhood Cancers

Childhood/juvenile Solid Organ Transplants (i.e. heart and/or lung, kidney)